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Abstract.  Thrombin cleavage of bovine brain 
microtubule-associated protein (MAP-2) yields two sta- 
ble limit polypeptide fragments (28,000 and 240000 
Mr).  The smaller cleavage product contains the 
microtubule-binding  domain and is derived from the 
carboxyl terminus of MAP-2 while the 240,000 Mr 
fragment is derived from the amino terminus.  The 
amino terminal  sequence of the smaller cleavage prod- 
uct is homologous with the microtubule-binding  frag- 
ment of tau in sequence and in a  similar location 
relative to three imperfect octadecapeptide repeats 
implicated in microtubule binding.  Peptides corre- 
sponding to the cleavage site and the three repeats of 
MAP-2 were synthesized.  Only the second octadeca- 
peptide repeat (VTSKCGSLKNIRHRPGGG) was capa- 
ble of stimulating  microtubule nucleation and elonga- 
tion.  Microtubules formed in the presence of this 
peptide displayed normal morphology and retained the 
inhibition properties of calcium ion, podophyllotoxin, 
and colchicine.  Our result indicates that a  region com- 
prising only '~1%  of the MAP-2 sequence can pro- 
mote microtubule assembly. 
C 
ONSIDERING the wide variety  of microtubule func- 
tions,  the need for temporal, spatial,  and metabolic 
control of microtubule assembly/disassembly is quite 
evident (Purich and Kristofferson,  1984; Olmsted, 1986). In 
this regard,  it is not surprising  that there should be a large 
number of proteins,  beyond tubulin per se,  that  influence 
microtubule  self-assembly.  Such  proteins  are  collectively 
known  as  microtubule-associated  proteins  (MAPs)  l,  and 
they include  the MAP-l, MAP-2, and tau protein  families. 
The designation  of proteins as MAPs has been based opera- 
tionally  on their ability  to purify with assembled microtu- 
bules through cycles of warm-induced assembly and cold de- 
polymerization. More recently,  however, sequence data on 
the  MAP-2  and  tau  proteins  suggest  that  they  share  a 
microtubule-binding  motif (Lewis et al.,  1988),  and three 
imperfectly repeated sequences have been postulated to con- 
stitute the microtubule-binding  site. Aizawa et al. (1988) also 
observed that  chymotrypsin  cleavage  of tau  occurs  at  a 
specific  proline-rich  sequence, defining  the NH2 terminus 
of the microtubule-binding  fragment in the tau proteins.  We 
have investigated the site of thrombin cleavage of MAP-2 be- 
cause our earlier  studies  had  shown  that  this  Mr  28,000 
thrombin cleavage fragment binds to both microtubules and 
neurofilaments  (Flynn  et al.,  1987).  We now report that 
G. Flynn's present address is the Department of Molecular Biology, Prince- 
ton University,  Princeton, NJ. 
1. Abbreviation  used in this paper:  MAE microtubule-associated  protein. 
thrombin attacks a region of MAP-2 that corresponds to the 
site of chymotrypsin cleavage of tau. Furthermore, by using 
oligopeptides corresponding to the NH2 terminus  and the 
three imperfect repeats in the MAP-2 binding fragment,  we 
have explored the ability of such peptides to stimulate micro- 
tubule assembly. Our results suggest only the peptide corre- 
sponding  to the second repeat can promote nucleation  and 
elongation  of microtubules. 
Materials and Methods 
Materials 
['y32p]ATP (7,000 Ci/mmol) and [3H]GTP  (18 Ci/mmol) were purchased 
from ICN (ICN Radiocbemicals,  Irvine, CA) along with ultrapure grades 
of ammonium sulfate, SDS, acrylamide, and bis-acrylamide (ICN Biomedi- 
cals,  Irvine, CA). Acetate kinase was a product of Boehringer Mannheim 
Biochemicals (Indianapolis,  IN),  while phosphocellulose resin was from 
Whatman Inc.  (Clifton,  NJ).  Immobilon was  obtained  from  Millipore 
Continental Water  Systems  (Bedford,  MA).  DEAE-Sephadex A-50  was 
purchased from Pharmacia Fine Chemicals (Piscataway, NJ), and bovine 
thrombin, trifluoracetic  acid,  Mes buffer,  and PMSF were  from Sigma 
Chemical Co. (St. Louis,  MO). t-BOC amino acids and phenylacetamido- 
methyl  resin were from Applied Biosystems Inc.  (Foster City, CA). 
Preparation of  Proteins 
Bovine brain microtubule protein was prepared by the procedure of Shelan- 
ski et al. (1973). MAP-2 was purified by the method of Herzog and Weber 
(1978) and radiolabeled as previously described (Flynn et al., 1987). Phos- 
phocellulose  purified tubulin was prepared according to Kristofferson et al. 
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made with a synthesizer (model 430A; Applied Biosystems Inc.) according 
to the method of Erickson and  Merrifield (1976)  with t-BOC  protected 
amino acids and starting with a phenylacetamidoethyl resin. Peptides were 
cleaved and deprotected using a mixture of hydrogen fluoride, anisole, and 
dimethyl sulfide in a 9:1:0.3 ratio (vol/vol) at -10*C for 2.5 h. After evapo- 
ration the resin was washed with cold diethyl ether and extracted into 1 M 
acetic acid and then freeze dried. Purity was tested by HPLC profile or by 
gas phase microsequancing. The peptides were stored at -20°C as a lyophi- 
lizad powder. 
For the preparative isolation of the microtubule-binding fragment of 
MAP-2, heat-stable, microtubule-binding fragments were prepared accord- 
ing to Vallve (1986) with the following modifications. Thrombin, instead of 
chymotrypsin, was used at a concentration of 8 U/mi to digest microtubule- 
protein at 370C for 30 rain. PMSF was added to 1 mM at the end of the 
digestion to stop proteolysis. After sedimentation and heating the pellet frac- 
tion, the heat-stable binding fragments were concentrated by ammonium 
sulfate precipitation and then dialyzed against microtubule-assembly buffer 
(100 mM Mes, pH 6.8, I mM EGTA, and 1 mM magnesium sulfate) at 40C 
with 1 mM PMSF and passed over a  i  ml DEAE-Sephadex A-50 column 
equilibrated in the same buffer. The breakthrough fractions were pooled and 
precipitated with 60% (wt/vol) ammonium sulfate. After sedimentation, the 
precipitate was resuspended in assembly buffer and used for HPLC analysis 
or Immobilon blotting. 
HPLC and Sequence Analysis 
HPLC was carried out on a chromatograph (model 1090a;  Hewlett-Packard 
Co., Palo Alto, CA), equipped with a diode array detector. The protein was 
loaded on a C-18 column (Waters Associates, Milford, MA) equilibrated in 
0.1%  (vol/vol) trifluoroacetic acid,  and eluted with a  linear gradient of 
0-50% (vol/vol) acetonitrile with 0.1% (vol/vol) trifluoroacetic acid at a flow 
rate of 0.5 ml/min. Fractions containing the MAP-2 microtubule-binding 
domain were pooled, dialyzed against 100 mM ammonium bicarbonate, and 
lyophilized. 
Immobilon was handled according to the manufacturer's instructions be- 
fore electroblotting.  A  12%  acrylamide  SDS-gel containing heat-stable 
microtubule-binding fragments was electrophoretieally transferred to the 
membrane for 6 h at 70 V in 10 mM 3-[cyciohexylamino]-l-propane-sul- 
fonate, pH  10.0, with  10%  methanol. The membrane was stained with 
Coomassie brilliant blue R-250, dcstained in 50% methanol-10%  acetic acid, 
and the band of interest excised with a razor blade and sequenced in a gas- 
phase protein sequencer (model 470A; Applied Biosystems Inc.) with on- 
line phenylthiohydantoin analyzer.  Ultrapure grades of SDS, aerylamide, 
and bis-acrylamide were used to avoid blocking the NH2 terminus. 
In the absence of thrombin treatment, identical sequence experiments. 
with either electroblotted MAP-2, as well as MAP-2 in solution, did not 
yield any phenylthiohydantoin derivatized amino acids at detectable levels. 
Likewise, experiments with the immobilized 240,000-Mr  projection-arm 
fragment yielded no sequence data. Protein samples failing to yield detect- 
able levels of amino acid derivatives were subjected to acid-catalyzed hy- 
drolysis and amino acid analysis to assure that sufficient levels of protein 
for sequencing had been employed. These findings suggest that the amino 
terminus of MAP-2 is blocked and that the 240,000-Mr  fragment lies at the 
amino terminus whereas the 28,000-Mr  fragment resides at the carboxyl 
end. These observations are in accord with the findings by Kosik et al. 
(1988)  who  reported  that  the  NH2  terminus  of MAP-2  appears  to  be 
blocked. 
Microtubule Assembly with Synthetic Peptides 
All assembly experiments were done with a GTP-regenerating system (Mac- 
Neal et ai.,  1977)  consisting of 2  U/ml of acetate kinase,  10 mM acetyl 
phosphate (Sigma Chemical Co.), and 0.1 mM [3H]GTP (20 Ci/ml). All 
assay mixes also contained 1 mM [YrT. Peptides were weighed out just be- 
fore use and dissolved in 100 mM Pipes, pH 6.8, 1 mM EGTA, 1 mM mag- 
nesium sulfate with  1 mM DTL  Varying concentrations of each peptide 
were added to 1.6 mg/ml pure tubulin and 0.4 mg/rnl three cycle microtu- 
bule-protein and incubated at 30°C for 30 min. The extent of microtubule 
assembly was monitored by the rapid filtration assay of Maccioni and Seeds 
(1978) as modified by Wilson et al. (1982).  Microtubules were diluted 20x 
into 100 mM Pipes, pH 6.8,  1 mM EGTA,  1 mM magnesium sulfate, 1% 
glutaraldehyde (Sigma Chemical Co.),  10% dimethylsulfoxide, 25% glyc- 
erol, and 1 mM ATP and kept at 30"C until ready to assay. The diluted mix- 
ture was then applied to GF/F filters on a vacuum filtration device (Hoeffer 
Scientific Instruments, San Francisco, CA) presoaked in the same buffer ex- 
cept no glutaraldehyde was used. Each filter was then washed with 15 ml 
of the same buffer and the radioactivity was solubilized in  1.5 ml 0.1 N 
NaOH for 30 min followed by addition of scintillation cocktail (Research 
Products International Corp., Mt.  Prospect, IL). 
Preparation of  Microtubule Seeds and 
Elongation Assay 
Microtubule fragments or seeds were prepared according to Kristofferson 
et al. (1986). Tubulin at 5 mg/ml was assembled with 1 mM GTP in 80 mM 
Pipes, pH 6.8, 10 mM magnesium chloride, 1 mM EGTA, in 30% glycerol 
at 37°C for 30 min. The microtubules were then sheared with three passes 
through a 22-gauge needle to produce microtubule seeds. The seeds were 
diluted 100×  (vol/vol) into solutions containing 0.5 mg/ml tubulin at vary- 
ing concentrations of peptides. After 30 rain at 37°C, the samples were han- 
dled as described in the preceding section for measurement of radioactive 
guanine nucleotide incorporation. 
Results 
Thrombin Cleavage of  MAP-2 and Purification of lts 
Microtubule-Binding Fragment 
Vallee (1980)  first demonstrated  that  MAP-2 can be frag- 
mented into 35,000- and 240,000-Mr components by chymo- 
trypsin or trypsin. The smaller fragment contains the micro- 
tubule-binding domain,  and the larger  is designated as the 
projection-arm domain. While these protease cleavage prod- 
ucts have been very useful in many investigations of microtu- 
bule self-assembly, cbymotryptic and tryptic cleavage do not 
yield stable limit polypeptides. Because thrombin is an argi- 
nine-specific  serine  protease,  we  reasoned  that  thrombin 
might display a simpler fragmentation pattern. MAP-2 cleav- 
age can be readily assessed by SDS gel electrophoresis of 
[32P]MAP-2 because this protein is extensively phosphoryl- 
ated (Theurkaufand Vallee, 1983). The projection-arm frag- 
ment contains many more phosphoryl aceeptor sites than the 
tubule-binding domain; even so, the stability of the 28,000- 
Mr  fragment  is evident in the autoradiogram  presented  in 
Fig.  1.  This  thrombin-produced  fragment  of MAP-2 pos- 
sesses the microtubule-binding  site as well as a neurofila- 
ment-binding site as previously reported (Flynn et al.,  1987). 
Amino-Terminal Sequence of the Microtubule-Binding 
Fragmen  t 
To gain more information about this site of facile thrombin 
cleavage,  we developed a high-yield isolation method (see 
Materials  and  Methods)  for amino  acid  analysis  and  se- 
quencing experiments. We employed protein microsequenc- 
ing techniques  with the 28,000-Mr  fragment electroblotted 
from SDS-polyacrylamide gels to a derivatized nylon screen 
(Immobilon).  We  obtained  the  amino  terminal  sequence 
shown in Fig. 2. Lewis et al. (1988) reported the entire de- 
rived  amino  acid  sequence  using  murine  MAP-2  eDNA 
clones. Our primary sequence data with bovine brain MAP-2 
correspond to the murine sequence spanning residues 1626- 
1644 with only three exceptions. 
As shown in Fig. 2, there is a similar protease-accessible 
sequence in the microtubule-binding fragment of bovine tau 
protein. In that case, however, fragments were generated by 
chymotryptic cleavage (Aizawa et al.,  1988).  Both of these 
cleavage-site sequences reside ,040-50 residues toward the 
NH2  terminal  side of the  first  of three  nonidentical  octa- 
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2 and purification of its microtubule-binding domain. Radiolabeled 
heat-stable  MAP-2  (32p, 50,000 epm//zg) was incubated  at  37°C 
with 4 U/ml thrombin for the indicated time in minutes. The diges- 
tion was quenched by heating at 100°C for 5 min in the presence 
of SDS, and the products were resolved on a 15 % polyacrylamide 
gel. The gel was then dried  under  vacuum and exposed (X-AR 5 
film; Eastman Kodak Co., Rochester, NY). 
decapeptide repeats (indicated schematically by arrowheads) 
found in both MAP-2 and tau  (Lewis et al.,  1988;  Lee et 
al.,  1988). 
Peptide Interactions with Tubulin and 
Microtubule-Protein 
To analyze further sequence(s) responsible for MAP-2 bind- 
ing  to  tubulin  within  the  28,000-Mr  fragment,  we  synthe- 
sized  four peptides.  The  first (ms  =  TPHTPGTPK) cor- 
responded to the NH2 terminus of the 28,000-Mr fragment. 
The others  corresponded  to  the  three octadecapeptide  re- 
peats (m~  =  VKSKIGSTDNIKYQPKGG; m2  =  VTSKCG- 
SLKNIRHRPGGG; m3  =  AQAKVGSLDNAHHVPGGG). 
Peptide  ms  was  based  on  our  bovine  sequence  data.  We 
used the murine MAP-2 sequence data for m,, m2, and m~ 
because no such data are yet available for the bovine MAP-2. 
The high state of purity of each peptide was confirmed on 
the basis of HPLC elution profile analysis or gas-phase mi- 
crosequencing. 
We  sought  to  determine  whether  any of these  peptides 
would  influence  the  assembly of microtubule protein that 
contained  both  tubulin  and  MAPs.  We  first worked  with 
recycled microtubule protein to which sufficient pure tubulin 
was added to lower the content of MAPs to about one-fifth 
their normal level. This final composition was "~5 % MAPs 
and 95 % tubulin by weight. This ratio was chosen to accen- 
tuate any stimulatory effects of the peptides on the assembly 
process, and no microtubule polymerization occurred at the 
protein concentrations used without peptide addition. To as- 
say the extent of microtubule assembly at different levels of 
peptides  ms,  m,,  m2,  and  m3,  we  measured  [3H]guanine 
nucleotide uptake with the glass fiber filter assay of Maccioni 
and Seeds (1978)  as modified by Wilson et al. (1982).  Only 
peptide m2, corresponding to the second repeat in MAP-2, 
stimulated microtubule-assembly as evidenced by the data 
shown  in  Fig.  3.  When  peptides ms,  m,,  or m3 were em- 
ployed, no incorporation of guanine nucleotide was observed 
above background levels.  Moreover, in companion experi- 
ments, we found that none of these peptides altered the stim- 
ulation  of microtubule  assembly by  peptide  m2.  We  also 
tested the action of several common inhibitors of microtubule 
assembly to learn whether peptide m2 induced assembly in 
a manner akin to normal assembly of brain microtubules. In- 
clusion  of colchicine  (0.1 mM),  calcium  ion  (2  mM),  or 
podophyllotoxin (0.1 mM) resulted in complete inhibition of 
peptide m2-induced assembly. 
We also  found  that  assembly of pure  tubulin  could  be 
stimulated by m2 only.  Indeed,  assembly with tubulin  and 
m2  exhibits  a  typical  time-course  for  the  polymerization 
process as shown in Fig. 4 A.  Without addition of m2 pep- 
tide, no tritium label is retained on the glass fiber filters. We 
verified that the observed polymerization resulted in micro- 
tubules by using EM and immunofluorescence microscopy 
(data  not  shown).  When  tubulin  (1  mg/ml) was incubated 
with and  without  peptide m2  (1  mM),  intact microtubules 
were observed only in those micrographs of samples to which 
this peptide had been added.  This concentration of tubulin 
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Figure 2.  Comparison  of proteolytic  fragmentation 
patterns and the amino terminal sequences of the mi- 
crotuhule-binding  fragments of MAP-2 and tau pro- 
tein. The polypeptide chains and cleavage patterns for 
MAP-2 and tau are represented  as heavy lines.  The 
closed  circles  represent  the  blocked  MAP-2  NH2- 
terminus, and the underlined amino acid residues rep- 
resent identical and/or conserved amino acid residues 
common to both MAP-2 and tau proteins. The tau pro- 
tein  scheme  is  based  on the  data  of Aizawa et al. 
(1988) and Lewis et al.  (1988). 
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Figure 3. Stimulation of microtubule assembly with synthetic pep- 
tides. Varying concentrations of each peptide were added to  1.6 
mg/ml tubulin and 0.4 mg/ml microtubule protein in the presence 
of [3ttlGTP  and  a  GTP-regenerating system (MacNeal  et  al., 
1977). After reaching steady state, the amount of GTP incorpora- 
tion was determined by the filtration assay of Maccioni and Seeds 
(1978) as  modified by Wilson et al.  (1982) (see Materials and 
Methods). 
was clearly above the critical concentration for peptide m2- 
induced assembly, whereas it was near the critical concentra- 
tion for polymerization of pure tubulin (see Fig. 4 B). 
These  observations  indicate  that  only  the  peptide  m2, 
with a sequence corresponding to the second repeated region 
of the microtubule-binding fragment MAP-2 could stimulate 
tubulin assembly. Nonetheless, the possibility remained that 
the other peptides could still promote elongation, but not 
nucleation, of microtubule assembly. To investigate this pos- 
sibility, we added preformed microtubule seeds (see Mate- 
rials and Methods) to tubulin (0.5  mg/ml) and [3H]GTP in 
the presence or absence of the peptides. Without any peptide 
additions, only a minimal increase in guanine nucleotide in- 
corporation was observed; however, upon addition ofpeptide 
m2,  significant assembly was again observed. By contrast, 
peptides m; and m3 failed to cause any significant increase 
of labeled guanine nucleotide incorporation into microtu- 
bules beyond background levels (Fig.  5).  Thus, m2 is the 
only peptide that can stimulate nucleation and elongation. 
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Figure 4. Assembly curve and critical concentration plot of  peptide- 
induced assembly. Phosphocellulose-purified tubulin (1.0 mg/ml) 
was incubated with m~ peptide (1.0 mM) at 37°C. At the indicated 
times in A, the amount of GTP incorporation was determined as 
described  earlier.  In B,  varying concentrations  of tubulin plus 
microtubule seeds, prepared as described in Materials and Meth- 
ods, were mixed with or without m2 peptide (1.0 mM at 37°C and 
assayed for GTP incorporation 30 min after addition of microtubule 
seeds. 
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Figure 5. Seeded assembly tubulin with synthetic peptides. Micro- 
tubule seeds prepared as described under Materials and Methods, 
were added to a solution containing 0.5 mg/ml tubulin (a level below 
the critical  concentration).  At the concentrations shown in the 
graph, mr, m2, and m3 were added and polymerization initiated by 
warming to 37°C. The plotted values correspond to radiolabel in- 
corporation 30 min after addition of seeds. 
Discussion 
The experiments described in this report were designed to 
gain further insight about the microtubule-binding fragment 
of MAP-2. We have identified a common protease-accessible 
site in MAP-2 and tau proteins, and we have demonstrated 
that a  single octadecapeptide corresponding to the second 
repeated sequence (from Val-1705 through Gly-1722 in mu- 
rine MAP-2) promoted microtubule nucleation and elonga- 
tion.  Thus,  a  sequence amounting to ,,o1% of the overall 
MAP-2 molecule is sufficient to interact with tubulin, but 
some additional considerations of MAP-2 structure seem ap- 
propriate. 
There is  now general  agreement that initial proteolytic 
cleavage of MAP-2 yields two flagments (Vallee, 1980; Flynn 
et at., 1987). With thrombin, these initial cleavage products 
corresponding to values of 240,000- and 28,000-M, based 
on electrophoresis, are quite stable with regard to further 
degradation. A striking common structural feature in MAP-2 
and tau emerges from the combined findings of Aizawa et al. 
(1988) and our studies. The former found that chymotryptic 
cleavage of the bovine tau proteins yielded a microtubule- 
binding fragment with the NH2 terminal sequence shown in 
Fig. 2, and we have now demonstrated that thrombin attacks 
at a similarly accessible region in bovine MAP-2 (See also 
Fig. 2). The reader should note that both of these cytomatrix 
proteins have four proline residues in exact registration, and 
with the exception of  the occurrence ofa val-pro in the MAP- 
2  sequence, each of the prolines in both cleavage sites is 
preceded by a hydroxy-amino acid.  Efforts to survey other 
known sequences in the GenBank database have indicated the 
uniqueness of these protease-accessible regions in tau and 
MAP-2; however, Earnshaw et al. (1987) described a centro- 
mere-binding position containing three prolines in exactly 
corresponding positions with little other structural related- 
ness to tau and MAP-2. The circular dichroism spectral data 
of Hernandez et al. (1986) indicates that uncleaved MAP-2 
contains little, if any, alpha helical or pleated-sheet second- 
ary structure; yet, the preferential action of the endoprotease 
thrombin at a single site suggests that MAP-2 may display 
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region of myosin. This region may permit the projection arm 
to swing away from the microtubule surface. Certainly, the 
observed sedimentation coefficient of 4.5 (Hernandez et al., 
1986) also suggests that MAP-2 has extended a flexible struc- 
ture. The roughly spherical hemoglobin molecule, itself only 
one-third the molecular mass of MAP-2, has an almost iden- 
tical sedimentation coefficient (Sanders et al.,  1981). Chy- 
motryptic cleavage between Tyr-128 and Ser-129 in the tau 
proteins may reflect a corresponding protease-accessible site 
of structural discontinuity between microtubule-binding and 
projection domains. 
That the second repeated sequence in MAP-2 can promote 
microtubule assembly  is  indeed  interesting.  Lewis  et al. 
(1988) had studied microtubule binding of an in vitro transla- 
tion product spanning amino acids 1621-1722 (including the 
first and  second repeated sequences).  While they did not 
demonstrate promotion of microtubule assembly, Lewis et 
al. (1988) succeeded in showing that their radioactively la- 
beled 100-residue polypeptide copurified through two cycles 
of assembly/disassembly with MAP-containing microtubule 
protein. We found that a single octadecapeptide is effective, 
even in the absence of MAPs. While we cannot discount the 
possibility of multiple binding of peptide m2 to tubulin, es- 
tablishing the stoichiometry of ligand binding to a protein 
can be particularly challenging for ligands that bind in the 
millimolar concentration range. We should also emphasize 
that "-,0.5 mM of the peptide m2 is needed to promote as- 
sembly, but MAP-2 is effective in the 1-5-#M range. It takes 
an even higher concentration (1.0 mM) of m2 peptide to dis- 
place intact MAP-2 from microtubules; yet a peptide con- 
taining more of the adjacent sequences of m2 can displace 
MAP-2 at lower concentrations (Joly, J., and D. Purich, un- 
published observations). This may indicate that the several 
repeats in MAP-2 reinforce each other in promoting assem- 
bly or that our octadecapeptide cannot readily assume the 
assembly-promoting conformation. Obviously, the confor- 
mational latitude of the second repeated sequence could be 
greatly restricted by the other residues in the entire microtu- 
bule-binding domain of MAP-2. At this point, however, the 
combined findings of Lewis et al.  (1988) and our observa- 
tions attest to the importance of the second octadecapeptide 
in MAP-2 interactions with tubulin. 
The  peptide  corresponding  to  the  second  repeated  se- 
quence has an overall isoelectric point that is more basic than 
the first and third octadecapeptides (e.g., m~, m2, and m3 have 
calculated isoelectric points of 10.5, 11.6, and 8.0). In the as- 
sembly buffer (pH 6.8), m,, m2, and m3 have overall charges 
of +3,  +4, and +0.4, respectively. There are other indica- 
tions that ionic interactions are important in MAP-2 binding 
to tubnlin and/or microtubules. Flynn et al. (1987), for ex- 
ample, showed that the 28,000-Mr  tubule-binding fragment 
of MAP-2 had an isoelectric point of ~10.5 whereas the larger 
projection-arm fragment was considerably more anionic (iso- 
electric point *4.8). Moreover, anions such as polyglutamate 
and heparin sulfate are generally known to block MAP bind- 
ing to microtubules, and the MAP binding site on tubulin is 
thought to involve the glutamate-rich carboxyl-termini of the 
tubulin heterodimer. Nonetheless, we cannot conclude that 
ionic interactions alone determine the effectiveness  of peptides 
in promoting assembly. 
Most recently, oligopeptide sequences from tau and a 190- 
kD bovine adrenal gland MAP were shown to possess the 
ability to polymerize microtubules (Ennulat et al.,  1989; 
Aizawa et al.,  1989). The first and second octadecapeptide 
repeats in tau were shown to promote microtubule polymer- 
ization, but the third was ineffective. The first repeated se- 
quence in MAP-2 cannot induce microtubule assembly, un- 
like its counterpart in tau.  The only significant difference 
between the two sequences is a lysine in place of a glycine 
near the carboxy terminus. This structural feature is an ex- 
cellent candidate for a/~-turn, and its disruption may pre- 
clude the ability of this peptide to stimulate microtubules. 
When this lysine is replaced by a glycine residue, the peptide 
can displace MAP-2 just as  effectively as the m2  peptide 
(Joly, J.,  and  D.  Purich,  unpublished  observations).  The 
assembly-promoting sequence in the 190-kD adrenal MAP 
was very similar to the first repeated sequence in tau and pro- 
duced microtubules of normal morphology. We have com- 
pared the sequences (see Fig. 6) to identify common features 
in  the  assembly-promoting  sequences.  For  this  purpose, 
these peptide sequences were brought into registration with 
(+)  (+)  (-)  (+)  (+) 
m  I  Val-Lys-Ser-Lys-Ile-Gly-Ser-Tnr-Asp-Asn-Ile-Lys-Tyr~in-Pro-Lys~ly-Gly 
(+)  (+)  (-)  (+)  ~+ 
t  I  Val  -Arg-Ser-Lys-I  i  e-Gly-Ser-qhr-Glu-Asn-Leu-Lys-His-Gln-Pro-Gly-Gly-Gly 
(+)  (+)  (+)  (-)  (+)  ~+  (+)  (+) 
ag  Lys-Asn-Val-Ar~-Ser-Lys-Val -Gly-Ser-qhr-Glu-Asn-I le-Lys-His-Gln-Pro-Gly-Gly-Gly-Arg-Ala-Lys 
(-) 
(+) 
(+) 
(+)  (+)  (+)  ~+  (+) 
m  2  Val-Tnr-Ser-Lys-Cys-Gly-Ser-leu-Lys-Asn-Ile-Arg-His-Arg-Pro-Gly-Gly-Gly  (+) 
(+)  6+  6+  (+) 
t  2  Val-Tnr-Ser-Lys-Cys-Gly-Ser-leu-Gly-Asn-Ile-His-His-Lys-Pro-Gly-Gly-Gly  (+) 
(+)  (-)  6+  6+ 
m  3  Ala-Gln-Ala-Lys-Val-Gly-Ser-leu-Asp-Asn-Al  a-His-His-Val-Pro-Gly-Gly-Gly  (-) 
(+)  (-)  ~+ 
t  3  Val-Gln-Ser-Lys-I le-Gly-Ser-Leu-Asp-Asn-I leWlhr-His-val  -Prp-Gly-Gly-Gly  (-) 
Figure 6. The octadecapeptide repeats of MAP-2 (m~, m2, and m3), and tau (t,, t2, and t3),  and a corresponding sequence of the 190-kD 
adrenal gland MAP (ag) are shown. The (+) signs represent full positive charges at pH 6.8, whereas the delta represents partially positive 
imidazolium side-chain groups of histidyl residues. Plus and minus signs at the right of each peptide indicate assembly and no assembly, 
respectively. 
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all peptides have a common lysyl residue near their amino 
termini. Likewise, all assembly-promoting peptides contain 
one, or more, full positive charge(s) on residues near the 
pro-X-gly-gly sequence.  Peptides m3 and t3 lack this latter 
feature and cannot stimulate assembly, suggesting that the 
partially charged histidyl residues  offer insufficient ionic 
character at these sites. Interestingly, the presence of  positive 
charge in the middle of the m2 sequence does not preclude 
assembly; however,  introduction of positive charge in the 
pro-lys-gly-gly of m, abolishes promotion of tubulin poly- 
merization. 
Finally, the observations that several octadecapeptides can 
promote assembly suggests a route for preparing low molec- 
ular mass modulators of microtubule assembly. As more in- 
formation on the binding of MAPs to tubulin is developed, 
we may be able to improve the binding efficiency of these 
oligopeptides. Moreover, the availability of these peptides 
should permit additional studies of MAPs binding to other 
cytoskeletal elements including the neurofilament proteins. 
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